Early Clinical Trial Network
Potentially severe side and/or novel effects may occur at any time in early-stage trials therefore treatment by a dedicated and experienced team of investigators and study nurses and within a safe environment is critical. These prerequisites are met at all Early Clinical Trial Units (ECTUs) within our Network. The network aims to continuously improve the quality of clinical trial conduct at all centers, in order to ensure patient safety during ongoing and future early phase trials.
As the efficacy of molecular-targeted therapeutics is often restricted to rare genetically defined subgroups, timely recruitment has become a major challenge in current early phase clinical trials. The ECT.net addresses this challenge by combining high-volume centers of excellence in hematology and oncology. By jointly treating more than 15.000 cancer patients each year, we are able to run trials for even very infrequent diseases or subgroups.
Service for Sponsors and CROs
- Single central contact point
- Rapid feasibility process
- Site project management
- Access to more than 15.000 cancer patients each year
- Performance reporting
- Consulting in protocol design
Service for Academic Partners
- Active sales & promotion
- Budget calculation
- Contract & project management
- Risk management
- Performance reporting
Kommentarbereich geschlossen.